Lila Bio
Lila Bio develops therapeutic proteins using AI-powered protein design and experimental discovery platforms. Its targeted radiotherapy platform focuses on solid tumors, while its long-acting injectable platform targets non-oncology diseases; the company aims to develop medicines that improve care for people with cancer and other debilitating diseases.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2023
- Employees
- 10
- Members see funding amounts. .
- Founders
- Jake Kraft, PhD, Anindya Roy, PhD, Hua Bai, PhD, Sheila Gujrathi, MD
Is this your organization? Claim it
Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed long‑acting injectable for pulmonary hypertension
Lila Bio, spun out of David Baker’s UW lab, won a $3.65 million NIH SBIR grant to develop an AI-designed, long-acting injectable protein therapy aimed at modifying disease in pulmonary hypertension. The funding covers two phases—$605,981 for initial animal studies and $3,049,462 for further animal work and patient lung-tissue studies—and builds on Lila’s 2023 $10M seed raise and prior collaboration with Eli Lilly.
Lila Bio wins $3.65M NIH SBIR grant to build AI-designed proteins for pulmonary hypertension
Lila Bio won a $3.65 million NIH SBIR fast-track grant to develop AI-designed therapeutic proteins for pulmonary hypertension, receiving an initial $605,981 phase followed by $3,049,462 in a second phase. The Seattle startup, founded in 2023 by Jake Kraft and Anindya Roy, previously raised a $10 million seed round and will use the non-dilutive funding to advance candidates toward clinical utility.
Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed protein therapy for pulmonary hypertension
Lila Bio received a $3.65 million NIH SBIR grant to develop AI-designed, long-acting injectable protein therapies that aim to modify the underlying disease in pulmonary hypertension; initial work is in lab and animal testing with further studies planned using patient lung tissue.
See all 10 news stories about Lila Bio.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 4-
Anindya Roy Executive Officer, Director, CSO & Co-Founder
-
Jake Kraft CEO & Co-Founder
-
Hua Bai Director of Protein Design & Co-Founder